Cognitive Enhancement Protocol: Semax & Selank

Category: Stacks Type: Protocol Read Time: 16 minutes Author: Peptides.NYC Editorial Last Updated: 2026-05-19 URL: https://peptides.nyc/learn/cognitive-peptide-stack

Educational content only. Not medical advice. Consult a licensed healthcare provider before starting any protocol.

Overview

Semax and Selank are two Russian-developed neuropeptides that have become the cornerstone of modern nootropic peptide stacks. Both are administered intranasally, both originate from decades of Soviet and post-Soviet neuropharmacology research, and both are approved as prescription medications in Russia — though neither is FDA-approved in the United States.

Semax is an analog of fragments 4–10 of adrenocorticotropic hormone (ACTH), engineered to remove hormonal activity while preserving neurotropic effects. Selank is a synthetic analog of tuftsin, a tetrapeptide naturally found in immunoglobulin G. Their effects are opposing-but-complementary: Semax tends to push focus, drive, and dopaminergic tone upward, while Selank exerts a calming, anxiolytic influence without the sedation typical of benzodiazepines.

Stacked together, the result that most users describe is "calm focus" — the productivity profile of a stimulant without the agitation, and the composure of an anxiolytic without the cognitive blunting.

Why Stack Them

Semax and Selank are routinely paired because each compensates for the trade-offs of the other.

Semax brings:

• BDNF and NGF gene upregulation (neurotrophic support)
• Increased dopaminergic and serotonergic tone
• Sharper attention and motivation
• Mild stimulating profile

Selank brings:

• GABA(A) receptor modulation (anxiolysis)
• Enkephalin pathway stabilization
• Calmer affect without sedation
• No documented dependence or tolerance signature

The practical outcome of stacking is that Semax's "drive" is tempered by Selank's anxiolytic baseline, allowing extended cognitive work without the over-arousal that can otherwise show up as jitteriness, racing thoughts, or end-of-day fatigue.

Semax Mechanism

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) acts primarily through the melanocortin system, but most of its cognitive effects are attributed to downstream neurotrophic signaling.

Key mechanisms:

1. BDNF and NGF upregulation — Semax acutely increases brain-derived neurotrophic factor and nerve growth factor in cortical and hippocampal tissue, supporting synaptic plasticity and learning consolidation.
2. Melanocortin pathway — Binds melanocortin receptors (notably MC4R) without producing ACTH's hormonal cortisol-driving effects.
3. Dopaminergic modulation — Increases dopamine and metabolite turnover in striatal regions, contributing to its motivational profile.
4. Neuroprotection — Russian clinical literature (Ashmarin and colleagues) describes use in ischemic stroke protocols, where Semax appears to limit neuronal damage and accelerate functional recovery.
5. Enkephalinase inhibition — Slows degradation of endogenous enkephalins, contributing to mood-stabilizing effects.

Onset is typically 15–30 minutes after intranasal administration, with effects lasting 4–6 hours.

Selank Mechanism

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is built around the tuftsin core (Thr-Lys-Pro-Arg) with a stabilizing C-terminal extension. It produces anxiolysis through a different pathway than benzodiazepines or SSRIs.

Key mechanisms:

1. GABA(A) modulation — Indirectly enhances GABAergic tone without binding the benzodiazepine site directly, which is thought to explain the absence of tolerance.
2. Enkephalin stabilization — Like Semax, it inhibits enkephalin-degrading enzymes, prolonging endogenous opioid signaling implicated in mood regulation.
3. Serotonergic and noradrenergic effects — Modulates monoamine balance in a way that produces anxiolysis without sedation.
4. Immunomodulation — As a tuftsin analog, retains modest immune-modulating activity.
5. Anxiolytic without dependence — Russian trials (Kost, Inozemtseva, and others) report sustained anxiolysis over multi-week dosing with no withdrawal signature on discontinuation.

Onset is typically 30–60 minutes intranasally; effects last 4–8 hours.

Dosing Protocols

Both peptides are formulated as preserved aqueous nasal sprays. The standard Russian pharmacy formulations are 0.1% Semax (1 mg/mL, approximately 300 mcg per metered spray) and 0.15% Selank (1.5 mg/mL, approximately 450 mcg per metered spray). N-acetylated research forms are typically dosed lower because of higher potency.

Administration Technique

1. Clear nasal passages gently before dosing.
2. Tilt head slightly forward, not backward.
3. Spray into one nostril while breathing in slowly.
4. Alternate nostrils across sprays.
5. Avoid blowing nose for 10–15 minutes after.

N-Acetyl vs Standard Forms

Both peptides exist in two main variants on the research market: the standard sequences sold in Russian pharmacies, and the N-acetylated amidated analogs commonly synthesized for research use.

Standard Semax / Selank

• Closer to clinical formulations used in Russia.
• Shorter half-life (hours).
• Lower per-dose potency.
• More forgiving for new users titrating effect.

N-Acetyl Semax Amidate (NASA) / N-Acetyl Selank Amidate (NAS-A)

• N-terminal acetylation and C-terminal amidation increase enzymatic resistance.
• Reported longer duration of action (often 6–10 hours).
• Higher per-dose potency — start with smaller volumes.
• Sold by research-chemical suppliers, not Russian pharmacies.

Which to choose:

• Beginners or those titrating: standard forms.
• Users wanting once-daily dosing or stronger effect: N-acetyl variants.
• Anyone sensitive to stimulating peptides: start with standard Semax, never N-acetyl, at the lowest dose.

Stacking Pattern

A typical day on a Semax + Selank stack looks like this:

Morning (within 30 minutes of waking)

• Semax: 1–3 sprays
• Optional: Selank 1 spray if baseline anxiety is elevated

Mid-morning to lunch

• Cognitive work window — Semax effect is peaking.

Early afternoon (post-lunch dip)

• Semax: 1–2 sprays (optional)
• Selank: 1–2 sprays if afternoon meetings or social load increases anxiety.

Late afternoon / evening

• Avoid additional Semax after ~3 PM — its stimulating effect can interfere with sleep onset.
• Selank is acceptable later in the day; some users dose it before social events.

Rules of thumb:

• Semax in the front half of the day; Selank anywhere.
• Do not mix the two into a single bottle — preservation systems and pH may differ.
• Wait 5–10 minutes between different intranasal peptides.

Expected Outcomes

Within 30–60 minutes:

• Semax: increased motivation, mental clarity, reduced mental fatigue.
• Selank: lowering of anxious baseline, smoother affect, reduced rumination.

First 1–2 weeks:

• More consistent focus throughout the workday.
• Reduced reactivity to stressors.
• Many users report better sleep onset despite the stimulating Semax profile (lower anxiety load).

Weeks 3–8:

• Cumulative effects on learning consolidation and memory retrieval.
• BDNF/NGF-driven plasticity benefits become more apparent.
• Sustained mood improvement from chronic Selank use.

These are subjective reports consistent with published Russian clinical data. Individual response varies, and these peptides are not a substitute for evaluation and treatment of attention or anxiety disorders.

Side Effects & Safety

Both Semax and Selank have favorable safety profiles in the published literature and in long-running user reports.

Common (mild, infrequent):

• Nasal irritation or dryness
• Mild headache
• Transient fatigue with Semax overdose (paradoxical effect)
• Brief lightheadedness on first dose

Theoretical or rare:

• Long-term effects of chronic melanocortin signaling are not well characterized in non-Russian populations.
• Possible interactions with monoamine-modulating medications (SSRIs, MAOIs, stimulants) — exercise caution.
• Pregnancy, breastfeeding, and pediatric use have not been adequately studied.

Not associated with:

• Physical dependence
• Withdrawal syndromes
• Cognitive blunting
• Documented serious adverse events at standard doses

If a sharp headache, persistent nasal irritation, or unusual mood change occurs, discontinue and consult a healthcare provider.

Cycling

Cycling philosophy differs between the two compounds.

Semax cycling

• Common pattern: 2–4 weeks on, 1–2 weeks off.
• Some long-term users dose daily without obvious tolerance.
• A short washout every 6–8 weeks is a conservative default.

Selank cycling

• Most users dose as-needed rather than continuously.
• Daily protocols (2–4 weeks on, 1–2 weeks off) are also reported.
• No documented tolerance, so cycling is more about pharmacological hygiene than necessity.

Combined cycle template (8-week block):

• Weeks 1–4: Daily Semax AM + Selank as needed.
• Weeks 5–6: Selank only, as needed; Semax off.
• Weeks 7–8: Resume both, or extend washout if no acute need.

Stacking Beyond Semax+Selank

Cognitive stacks can extend in either the neurotrophic or the stimulant direction. The table below summarizes commonly discussed adjuncts.

Adding more than one new compound at a time makes attribution of effects (and side effects) much harder. Introduce stack elements one at a time, with at least a week between changes.

Frequently Asked Questions

Q: Is Semax like Adderall? A: No. Semax is not a classic stimulant. It increases dopaminergic tone modestly and upregulates BDNF/NGF, producing focus without the heart-rate, blood-pressure, and tolerance issues associated with amphetamines. It is not a diagnostic or therapeutic substitute for ADHD treatment.

Q: Is Selank like a benzodiazepine? A: Selank modulates GABAergic tone but does not bind the benzodiazepine site of GABA(A). It produces anxiolysis without the sedation, cognitive impairment, or dependence characteristic of benzodiazepines. It is not a substitute for evaluation or treatment of an anxiety disorder.

Q: Can I combine Semax and Selank in the same spray bottle? A: Not recommended. The preservatives, pH, and stabilizers in pharmacy and research formulations differ. Use separate bottles and space sprays 5–10 minutes apart.

Q: Are these peptides safe long-term? A: Russian clinical use spans decades with a benign side-effect profile, but long-term Western-style trials are limited. Conservative cycling and routine bloodwork are reasonable hygiene.

Q: Where do these come from and how do I verify quality? A: Pharmacy-grade Semax and Selank are manufactured in Russia under prescription regulations. Research-grade and N-acetyl analogs come from synthesis labs. Look for third-party COAs with HPLC purity >98% and mass-spec confirmation. Avoid unbranded or pre-mixed nasal sprays from unknown sources.

Q: Can I use these with SSRIs or stimulant medications? A: There is theoretical interaction risk through shared monoamine pathways. Discuss with the prescribing clinician before adding either peptide. Do not self-titrate off prescribed medications to "make room" for a peptide stack.

Q: How fast will I feel something? A: Most users feel Semax within 15–30 minutes (sharper focus, slight uplift) and Selank within 30–60 minutes (lower anxiety baseline). Compound effects on learning and mood emerge over 2–4 weeks.

Q: What is the legal status in the US? A: Neither Semax nor Selank is FDA-approved. Both are sold in the US as research chemicals, and some users access them through compounding pharmacies via a licensed clinician. Personal-use importation rules vary; consult a legal professional for specifics.

Related Content

• Beginner's Stack Guide
• Peptide Safety Guide
• Peptide Legality Map 2026
• FDA Status Guide
• COA Reading Guide

Disclaimer: This content is for educational purposes only and is not medical advice. Semax and Selank are not FDA-approved in the United States. Consult a licensed healthcare provider before starting any peptide protocol, especially if you have a history of anxiety, mood, or attention disorders, or if you take medications that act on monoamine pathways.

Source: https://peptides.nyc/learn/cognitive-peptide-stack